About
Next-gen Gene Therapy
Areas of Focus
Categories
Contract ResearchContract ResearchContract ResearchDrug Delivery & FormulationChinaServices
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
15
As Collaborator
1
Total Enrollment
5,350
By Phase
PHASE1: 3PHASE2/PHASE3: 5PHASE2: 5NA: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 8ACTIVE_NOT_RECRUITING: 3COMPLETED: 2ENROLLING_BY_INVITATION: 2TERMINATED: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06980649Lead Sponsor
Study of BHV-1300 in Graves' Disease
PHASE1Recruiting
15 participants
Started: Aug 21, 2025 · Completed: Mar 31, 2026
NCT07054684Lead Sponsor
Study of BHV-1400 in IgA Nephropathy
PHASE1Recruiting
10 participants
Started: Jul 30, 2025 · Completed: Jul 31, 2026
NCT06976268Lead Sponsor
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
PHASE2/PHASE3Recruiting
550 participants
Started: May 28, 2025 · Completed: Sep 30, 2027
NCT06874335Lead Sponsor
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
PHASE1Recruiting
95 participants
Started: Mar 20, 2025 · Completed: Mar 31, 2029
NCT06603623Lead Sponsor
Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
PHASE2Completed
647 participants
Started: Oct 10, 2024 · Completed: Mar 28, 2025
Locations (1)
Headquarters
Nanjing, China
Map
Loading map...